Comparison of various non-invasive tools for diagnosing AL cardiac amyloidosis.

Investigation of left ventricular function and biomarkers following treatment in patients with light-chain cardiac amyloidosis

Predictors of progression of light-chain cardiac amyloidosis.

Prognosis of patients with cardiac amyloidosis referred in the French cardiac amyloidosis expert center.

AG10, an orally available, novel transthyretin (TTR) stabilizer: integrated preclinical evaluation predicts a highly effective treatment for TTR amyloid cardiomyopathy

Long-term evolution of longitudinal myocardial deformation in the natural history of familial amyloid polyneuropathy

Different features of cardiac involvement in patients with AL vs. TTR amyloidosis